1. Home
  2. SRRK vs EXP Comparison

SRRK vs EXP Comparison

Compare SRRK & EXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

N/A

Current Price

$53.87

Market Cap

6.8B

Sector

Health Care

ML Signal

N/A

Logo Eagle Materials Inc

EXP

Eagle Materials Inc

N/A

Current Price

$183.07

Market Cap

7.0B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
SRRK
EXP
Founded
2012
1963
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Building Materials
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
7.0B
IPO Year
2018
1994

Fundamental Metrics

Financial Performance
Metric
SRRK
EXP
Price
$53.87
$183.07
Analyst Decision
Strong Buy
Hold
Analyst Count
13
9
Target Price
$56.17
$227.11
AVG Volume (30 Days)
1.0M
321.4K
Earning Date
05-07-2026
05-19-2026
Dividend Yield
N/A
0.49%
EPS Growth
N/A
N/A
EPS
N/A
3.29
Revenue
N/A
$495,023,000.00
Revenue This Year
N/A
$1.97
Revenue Next Year
$534.24
$1.95
P/E Ratio
N/A
$56.27
Revenue Growth
N/A
N/A
52 Week Low
$27.07
$171.99
52 Week High
$61.76
$245.53

Technical Indicators

Market Signals
Indicator
SRRK
EXP
Relative Strength Index (RSI) 52.26 30.43
Support Level $44.26 $171.99
Resistance Level $58.49 $226.04
Average True Range (ATR) 2.35 4.72
MACD -0.38 -1.21
Stochastic Oscillator 23.61 0.25

Price Performance

Historical Comparison
SRRK
EXP

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

About EXP Eagle Materials Inc

Eagle Materials Inc produces and sells construction products and building materials. Construction products include cement, slag, concrete, and aggregates and building materials include cement and gypsum wallboard, and are sold to the construction and building industries. The firm organizes itself into two sectors: Heavy Materials, which includes the Cement and Concrete and Aggregates segments, and Light Materials, which includes the Gypsum Wallboard and Recycled Paperboard segments.

Share on Social Networks: